{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:13:17Z","timestamp":1790039597153,"version":"4.0.1"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SERB \/EEQ\/2019\/000521"],"award-info":[{"award-number":["SERB \/EEQ\/2019\/000521"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SERB \/ CRG \/2018\/002998"],"award-info":[{"award-number":["SERB \/ CRG \/2018\/002998"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008812","name":"Defence Science and Technology Group","doi-asserted-by":"publisher","award":["SR\/FST\/LSII-046\/2016"],"award-info":[{"award-number":["SR\/FST\/LSII-046\/2016"]}],"id":[{"id":"10.13039\/501100008812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","award":["SPARC\/2019-20\/P2450\/SL"],"award-info":[{"award-number":["SPARC\/2019-20\/P2450\/SL"]}],"id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.micpath.2026.108412","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T16:04:37Z","timestamp":1772294677000},"page":"108412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Global strategies to fight carbapenem-resistant Acinetobacter baumannii (CRAB) infections"],"prefix":"10.1016","volume":"214","author":[{"given":"Nilesh","family":"Makwana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip D.","family":"Karad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Dheeraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetna","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2571-4398","authenticated-orcid":false,"given":"Arun S.","family":"Kharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.micpath.2026.108412_bib1","article-title":"Emergence, molecular mechanisms, and global spread of carbapenem-resistant Acinetobacter baumannii","volume":"5","author":"Hamidian","year":"2019","journal-title":"Microb. Genom."},{"issue":"9","key":"10.1016\/j.micpath.2026.108412_bib2","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S1473-3099(23)00184-6","volume":"23","author":"Kaye","year":"2023","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.micpath.2026.108412_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11274-024-04106-8","article-title":"Mechanism-guided strategies for combating antibiotic resistance","volume":"40","author":"Sun","year":"2024","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00784-24","article-title":"\u03b2-Lactamase diversity in Acinetobacter baumannii","volume":"69","author":"Mack","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.micpath.2026.108412_bib5","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1111\/jam.15130","article-title":"Carbapenem resistance in Acinetobacter baumannii and their importance in hospital-acquired infections: a scientific review","volume":"131","author":"Nguyen","year":"2021","journal-title":"J. Appl. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2026.108412_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1017\/ice.2023.162","article-title":"Contribution of active surveillance cultures to the control of hospital-acquired carbapenem-resistant Acinetobacter baumannii in an endemic hospital setting","volume":"45","author":"Ben David","year":"2024","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"2","key":"10.1016\/j.micpath.2026.108412_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s40121-022-00597-w","article-title":"Carbapenem-resistant Acinetobacter baumannii: colonization, infection, and current treatment options","volume":"11","author":"Bartal","year":"2022","journal-title":"Infect. Dis. Ther."},{"issue":"8","key":"10.1016\/j.micpath.2026.108412_bib8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/antibiotics11081076","article-title":"Control of healthcare-associated carbapenem-resistant Acinetobacter baumannii by enhancement of infection control measures","volume":"11","author":"Wong","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2026.108412_bib9","doi-asserted-by":"crossref","unstructured":"Doughty EL, Liu H, Moran RA, Hua X, Ba X, et. al., Endemicity and diversification of carbapenem-resistant Acinetobacter baumannii in an intensive care unit. Lancet Reg. Health West. Pac. 37: 100780. doi:10.1016\/j.lanwpc.2023.100780.","DOI":"10.1016\/j.lanwpc.2023.100780"},{"key":"10.1016\/j.micpath.2026.108412_bib10","first-page":"Doc28","article-title":"Surveillance of health-care associated infections in an intensive care unit at a tertiary care hospital in Central India","volume":"18","author":"Lohiya","year":"2023","journal-title":"GMS Hyg Infect Control"},{"issue":"2","key":"10.1016\/j.micpath.2026.108412_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/QCO.0000000000001001","article-title":"Current treatment options for pneumonia caused by carbapenem-resistant Acinetobacter baumannii","volume":"37","author":"Franzone","year":"2024","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"WHO Pathogens Priority List Working Group. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.micpath.2026.108412_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QCO.0000000000000964","article-title":"What is the clinical significance of 'hetero-resistance' in nonfermenting Gram-negative strains?","volume":"36","author":"Tiseo","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05093-22","article-title":"Prevalence and clinical consequences of colistin heteroresistance and evolution into full resistance in carbapenem-resistant Acinetobacter baumannii","volume":"11","author":"Kon","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"12","key":"10.1016\/j.micpath.2026.108412_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311124","article-title":"Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: a comprehensive meta-analysis","volume":"19","author":"Beig","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00042-16","article-title":"Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in south and Southeast Asia","volume":"30","author":"Hsu","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"issue":"45","key":"10.1016\/j.micpath.2026.108412_bib18","doi-asserted-by":"crossref","first-page":"2001735","DOI":"10.2807\/1560-7917.ES.2020.25.45.2001735","article-title":"Epidemiological situation, laboratory capacity, and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe","volume":"25","author":"L\u00f6tsch","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.micpath.2026.108412_bib19","article-title":"Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"Suppl 2","key":"10.1016\/j.micpath.2026.108412_bib20","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1093\/cid\/ciad093","article-title":"Sulbactam-durlobactam: a step forward in treating carbapenem-resistant Acinetobacter baumannii (CRAB) infections","volume":"76","author":"Watkins","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.micpath.2026.108412_bib21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/antibiotics13070610","article-title":"Isolation and characterization of novel bacteriophages to target carbapenem-resistant Acinetobacter baumannii","volume":"13","author":"Choi","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.micpath.2026.108412_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3947\/ic.2024.0055","article-title":"Optimizing treatment for carbapenem-resistant Acinetobacter baumannii complex infections: a review of current evidence","volume":"56","author":"Choi","year":"2024","journal-title":"Infect Chemother"},{"key":"10.1016\/j.micpath.2026.108412_bib24","series-title":"Developing New Antibiotic Treatments for drug-resistant Infections","year":"2023"},{"issue":"Suppl 2","key":"10.1016\/j.micpath.2026.108412_bib116","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1093\/cid\/ciad094","article-title":"Navigating available treatment options for carbapenem-resistant acinetobacter baumannii-calcoaceticus complex infections","volume":"76","author":"Shields","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib117","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/pathogens10030373","article-title":"Acinetobacter baumannii antibiotic resistance mechanisms","volume":"10","author":"Kyriakidis","year":"2021","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.micpath.2026.108412_bib118","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14787210.2023.2184346","article-title":"Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?","volume":"21","author":"Ardebili","year":"2023","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib119","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/antibiotics9030119","article-title":"Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen","volume":"9","author":"Moubareck","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"Suppl 2","key":"10.1016\/j.micpath.2026.108412_bib25","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1093\/cid\/ciad109","article-title":"Global epidemiology and mechanisms of resistance of Acinetobacter baumannii-calcoaceticus complex","volume":"76","author":"Castanheira","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"10325","key":"10.1016\/j.micpath.2026.108412_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/AAC.49.1.202-208.2005","article-title":"OXA-58, a novel class D -Lactamase involved in resistance to carbapenems in Acinetobacter baumannii","volume":"49","author":"Poirel","year":"2005","journal-title":"antimicrobial Agents Chemother"},{"issue":"4","key":"10.1016\/j.micpath.2026.108412_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3201\/eid1304.060755","article-title":"Multidrug-resistant Acinetobacter baumannii, Russia","volume":"13","author":"Naas","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108412_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2334-8-80","article-title":"Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study","volume":"8","author":"Irfan","year":"2008","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108412_bib30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.diagmicrobio.2008.01.022","article-title":"Of the meropenem surveilance group. Evaluation of the susceptibility trends to meropenem in a nationwide collection of clinical isolates in Japan: a longitudinal analysis from 2002 to 2006","volume":"61","author":"Ishii","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"11","key":"10.1016\/j.micpath.2026.108412_bib31","first-page":"@051","article-title":"Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period","volume":"48","author":"Runnegar","year":"2010"},{"key":"10.1016\/j.micpath.2026.108412_bib32","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1093\/jac\/dkr390","article-title":"Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000\u201309)","volume":"66","author":"Gogou","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2026.108412_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijantimicag.2011.03.021","article-title":"Molecular detection of OXA carbapenemase genes in multidrug-resistant Acinetobacter baumannii isolates from Iraq and Georgia","volume":"38","author":"Kusradze","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2026.108412_bib34","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/j.ijid.2012.12.008","article-title":"Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase, Nigeria","volume":"17","author":"Olaitan","year":"2013","journal-title":"Int J Infect Disease"},{"key":"10.1016\/j.micpath.2026.108412_bib35","doi-asserted-by":"crossref","first-page":"e1255","DOI":"10.1016\/j.ijid.2013.07.016","article-title":"First report of NDM-1-producing Acinetobacter baumannii in East Africa","volume":"17","author":"Revathi","year":"2013","journal-title":"Int J Infect Disease"},{"key":"10.1016\/j.micpath.2026.108412_bib36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/1469-0691.12026","article-title":"Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005\u20132009)","volume":"19","author":"Schleisher","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085854","article-title":"Rapid molecular characterization of Acinetobacter baumannii clones with rep-PCR and evaluation of carbapenemase genes by New Multiplex PCR in Hospital district of Helsinki and Uusimaa","volume":"9","author":"Pasanen","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.micpath.2026.108412_bib38","first-page":"31","article-title":"Antimicrobial multi-resistance of Acinetobacter baumanii isolated from clinical specimens in douala (Cameroon)","volume":"1","author":"Ebongue","year":"2015","journal-title":"J. Dis. Med. Plants"},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib39","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1186\/s40064-016-2986-7","article-title":"Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007\u20132009)","volume":"5","author":"Kateete","year":"2016","journal-title":"SpringerPlus"},{"issue":"6","key":"10.1016\/j.micpath.2026.108412_bib40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/vaccines9060570","article-title":"Mapping global prevalence of Acinetobacter baumannii and recent vaccine development to tackle it","volume":"9","author":"Ma","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"10.1016\/j.micpath.2026.108412_bib41","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/jac\/dkx322","article-title":"High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy, and Spain as part of the MagicBullet clinical trial","volume":"72","author":"Nowak","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.micpath.2026.108412_bib42","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1128\/AAC.01259-06","article-title":"Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals","volume":"51","author":"Wang","year":"2007","journal-title":"Antimicrobial Agents Chemother"},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib43","first-page":"327","article-title":"Carbapenemases in Acinetobacter baumannii: review of their dissemination in Latin America","volume":"50","author":"Rodr\u00edguez","year":"2018","journal-title":"Rev. Argent. Microbiol."},{"key":"10.1016\/j.micpath.2026.108412_bib44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jgar.2020.08.015","article-title":"Characterisation of ST25 NDM-1-producing Acinetobacter spp. strains leading the increase in NDM-1 emergence in Argentina","volume":"23","author":"Rodgers","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"issue":"48","key":"10.1016\/j.micpath.2026.108412_bib45","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.15585\/mmwr.mm6948e1","article-title":"Increase in hospital-acquired carbapenem-resistant Acinetobacter baumannii infection and colonization in an acute care hospital during a surge in COVID-19 admissions \u2013 new Jersey, February-July 2020","volume":"69","author":"Perez","year":"2020","journal-title":"Morb. Mortal. Wkly. Rep."},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13756-021-00909-8","article-title":"The epidemiology of carbapenem resistance in Acinetobacter baumannii complex in Germany (2014-2018): an analysis of data from the national Antimicrobial Resistance Surveillance system","volume":"10","author":"Said","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"7","key":"10.1016\/j.micpath.2026.108412_bib47","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/antibiotics12071198","article-title":"Prevalence of carbapenemases in carbapenem-resistant Acinetobacter baumannii isolates from the Kingdom of Bahrain","volume":"12","author":"Al","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.micpath.2026.108412_bib48","first-page":"273","article-title":"National Antibiotic Surveillance Forum. Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa","volume":"97","author":"Brink","year":"2007","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.micpath.2026.108412_bib49","article-title":"A multiplex RPA coupled with CRISPR-Cas12a system for rapid and cost-effective identification of carbapenem-resistant Acinetobacter baumannii","volume":"15","author":"Zhou","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108412_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2024.100527","article-title":"Strategically reducing carbapenem-resistant Acinetobacter baumannii through PDCA cycle-driven antibiotic management","volume":"48","author":"Nie","year":"2024","journal-title":"Indian J. Med. Microbiol."},{"issue":"7","key":"10.1016\/j.micpath.2026.108412_bib51","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/antibiotics10070880","article-title":"In vitro synergy of colistin in combination with meropenem or tigecycline against carbapenem-resistant Acinetobacter baumannii","volume":"10","author":"Abdul Mutakabbir","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib52","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200131","article-title":"Colistin monotherapy versus combination therapy for carbapenem-resistant organisms","volume":"2","author":"Kaye","year":"2023","journal-title":"NEJM Evid."},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.010","article-title":"In vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii","volume":"55","author":"Seifert","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00542-22","article-title":"Activity of omadacycline alone and in combination against carbapenem-nonsusceptible Acinetobacter baumannii with varying minocycline susceptibility","volume":"10","author":"Abbey","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"5","key":"10.1016\/j.micpath.2026.108412_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00479-22","article-title":"Clinical outcomes of eravacycline in patients treated predominately for carbapenem-resistant Acinetobacter baumannii","volume":"10","author":"Alosaimy","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01471-21","article-title":"In vitro activity of KBP-7072 against 536 Acinetobacter baumannii complex isolates collected in China","volume":"10","author":"Han","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/antibiotics13010047","article-title":"Determining susceptibility and potential mediators of resistance for the novel polymyxin derivative, SPR206, in Acinetobacter baumannii","volume":"13","author":"Abdul-Mutakabbr","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"10.1016\/j.micpath.2026.108412_bib58","doi-asserted-by":"crossref","first-page":"651","DOI":"10.21037\/apm.2019.11.06","article-title":"Efficacy of tigecycline monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant Acinetobacter baumannii sequence type 2 in Heilongjiang Province","volume":"8","author":"Li","year":"2019","journal-title":"Ann. Palliat. Med."},{"issue":"7","key":"10.1016\/j.micpath.2026.108412_bib59","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/antibiotics12071172","article-title":"In vitro activity of cefiderocol against a global collection of carbapenem-resistant Acinetobacter baumannii isolates","volume":"12","author":"Seifert","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106825","article-title":"Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19","volume":"62","author":"Russo","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"24","key":"10.1016\/j.micpath.2026.108412_bib61","doi-asserted-by":"crossref","first-page":"15802","DOI":"10.1021\/acs.jmedchem.0c01535","article-title":"Discovery of ANT3310, a novel broad-spectrum serine \u03b2-lactamase inhibitor of the diazabicyclooctane class, which strongly potentiates meropenem activity against carbapenem-resistant Enterobacterales and Acinetobacter baumannii","volume":"63","author":"Davies","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108412_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.918868","article-title":"Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates","volume":"12","author":"Cedano","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108412_bib63","article-title":"Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii","author":"Park","year":"2024","journal-title":"Microbiol. Spectr."},{"issue":"8","key":"10.1016\/j.micpath.2026.108412_bib64","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/antibiotics10080903","article-title":"Clinical outcomes and safety of Meropenem\u2013Colistin versus Meropenem\u2013Tigecycline in patients with carbapenem-resistant Acinetobacter baumannii pneumonia","volume":"10","author":"Park","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2026.108412_bib66","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.csbj.2024.05.043","article-title":"Transcriptomic investigations of polymyxins and colistin\/sulbactam combination against carbapenem-resistant Acinetobacter baumannii","volume":"23","author":"Bian","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"6","key":"10.1016\/j.micpath.2026.108412_bib67","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/phar.2802","article-title":"Sulbactam-durlobactam: a novel \u03b2-lactam-\u03b2-lactamase inhibitor combination targeting carbapenem-resistant Acinetobacter baumannii infections","volume":"43","author":"El-Ghali","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.micpath.2026.108412_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.814530","article-title":"Activity of sulbactam-durlobactam and comparators against a national collection of carbapenem-resistant Acinetobacter baumannii isolates from Greece","volume":"11","author":"Petropoulou","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"12","key":"10.1016\/j.micpath.2026.108412_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210115","article-title":"Immunomodulatory role of interferons in viral and bacterial infections","volume":"24","author":"Mertowska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108412_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.735443","article-title":"GM-CSF: orchestrating the pulmonary response to infection","volume":"12","author":"McCormick","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib71","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/imr.13388","article-title":"Immune checkpoint inhibitors in infectious disease","volume":"328","author":"King","year":"2024","journal-title":"Immunol. Rev."},{"issue":"716","key":"10.1016\/j.micpath.2026.108412_bib72","doi-asserted-by":"crossref","first-page":"eadf9556","DOI":"10.1126\/scitranslmed.adf9556","article-title":"A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens","volume":"15","author":"Yan","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.micpath.2026.108412_bib73","doi-asserted-by":"crossref","first-page":"E399","DOI":"10.1002\/ajh.26313","article-title":"The impact of granulocyte colony-stimulating factor on patients receiving chimeric antigen receptor T-cell therapy","volume":"96","author":"Barreto","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.micpath.2026.108412_bib74","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1007\/s42770-024-01461-4","article-title":"Inside-out, antimicrobial resistance mediated by efflux pumps in clinical strains of Acinetobacter baumannii isolated from burn wound infections","volume":"55","author":"Hernandez-Duran","year":"2024","journal-title":"Braz. J. Microbiol."},{"issue":"9","key":"10.1016\/j.micpath.2026.108412_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00710-21","article-title":"Efflux pump overexpression profiling in Acinetobacter baumannii and study of new 1-(1-naphthylmethyl)-piperazine analogs as potential efflux inhibitors","volume":"65","author":"Choquet","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.micpath.2026.108412_bib76","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00203-023-03710-w","article-title":"A comprehensive profiling of quorum quenching by bacterial pigments identifies quorum sensing inhibition and antibiofilm action of prodigiosin against Acinetobacter baumannii","volume":"205","author":"Acharya","year":"2023","journal-title":"Arch. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib77","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001813","article-title":"In vitro and in silico assessment of anti-biofilm and anti-quorum sensing properties of 2,4-Di-tert butylphenol against Acinetobacter baumannii","volume":"73","author":"Jha","year":"2024","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib78","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12906-023-04147-w","article-title":"Medicinal plant Miconia albicans synergizes with ampicillin and ciprofloxacin against multidrug-resistant Acinetobacter baumannii and Staphylococcus aureus","volume":"23","author":"de Jesus","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib79","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12866-024-03194-8","article-title":"Regulation of overexpressed efflux pump encoding genes by cinnamon oil and trimethoprim to abolish carbapenem-resistant Acinetobacter baumannii clinical strains","volume":"24","author":"Saleh","year":"2024","journal-title":"BMC Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2026.108412_bib80","doi-asserted-by":"crossref","first-page":"536","DOI":"10.37201\/req\/012.2023","article-title":"Multidrug-resistant Acinetobacter baumannii: a therapeutic challenge","volume":"36","author":"Perez","year":"2023","journal-title":"Rev Esp Chimioter"},{"issue":"11","key":"10.1016\/j.micpath.2026.108412_bib81","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/acs.jnatprod.3c00490","article-title":"Integrating taxonomic and chemical diversity of mangrove-associated ascomycetes to discover or repurpose bioactive natural products","volume":"86","author":"Martinez-Aldino","year":"2023","journal-title":"J. Natural Prod."},{"issue":"10","key":"10.1016\/j.micpath.2026.108412_bib82","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1021\/acs.analchem.2c05351","article-title":"Single-cell metabolomics-based strategy for studying the mechanisms of drug action","volume":"95","author":"Zhu","year":"2023","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib83","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1038\/s41598-022-06582-0","article-title":"Enhanced antibacterial effect of a novel Friunavirus phage vWU2001 in combination with colistin against carbapenem-resistant Acinetobacter baumannii","volume":"12","author":"Wintachai","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib84","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41598-022-26696-9","article-title":"Characterization and sequencing of the novel phage Abp95, which is effective against multi-genotypes of carbapenem-resistant Acinetobacter baumannii","volume":"13","author":"Huang","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib85","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/v15030673","article-title":"Acinetobacter baumannii phages: past, present and future","volume":"15","author":"Tu","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108412_bib86","doi-asserted-by":"crossref","first-page":"ftae028","DOI":"10.1093\/femspd\/ftae028","article-title":"Characterization of bacteriophage vB_AbaS_SA1 and its synergistic effects with antibiotics against clinical multidrug-resistant Acinetobacter baumannii isolates","volume":"82","author":"Rastegar","year":"2024","journal-title":"Pathog Dis"},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib87","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1042\/BST20231289","article-title":"Making the leap from technique to treatment \u2013 genetic engineering is paving the way for more efficient phage therapy","volume":"52","author":"Lewis","year":"2024","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib88","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01923-21","article-title":"Development of an anti-Acinetobacter baumannii biofilm phage cocktail: genomic adaptation to the host","volume":"66","author":"Blasco","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2026.108412_bib89","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4274\/tjps.galenos.2021.72547","article-title":"Chitosan-based microparticle encapsulated Acinetobacter baumannii phage cocktail in hydrogel matrix for the management of multidrug-resistant chronic wound infection","volume":"19","author":"Ilomuanya","year":"2022","journal-title":"Turk J Pharm Sci"},{"key":"10.1016\/j.micpath.2026.108412_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.831037","article-title":"Peptidomimetics as potential anti-virulence drugs against resistant bacterial pathogens","volume":"13","author":"Martinez","year":"2022","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib91","doi-asserted-by":"crossref","first-page":"lxaf031","DOI":"10.1093\/jambio\/lxaf031","article-title":"Antimicrobial activity of peptoids against Metallo-\u03b2-lactamase-producing Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and other WHO priority pathogens, including Candida auris","volume":"136","author":"Mishra","year":"2025","journal-title":"J. Appl. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib92","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12011-019-01962-6","article-title":"The efficacy of imipenem conjugated with synthesized silver nanoparticles against Acinetobacter baumannii clinical isolates, Iran","volume":"197","author":"Zendegani","year":"2020","journal-title":"Biol. Trace Elem. Res."},{"issue":"2","key":"10.1016\/j.micpath.2026.108412_bib93","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1021\/acsomega.9b03644","article-title":"Assessment of molecular mechanism of gallate-polyvinylpyrrolidone-capped hybrid silver nanoparticles against carbapenem-resistant Acinetobacter baumannii","volume":"5","author":"Tiwari","year":"2020","journal-title":"ACS Omega"},{"issue":"22","key":"10.1016\/j.micpath.2026.108412_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212520","article-title":"Antiseptic 9-meric peptide with potency against carbapenem-resistant Acinetobacter baumannii infection","volume":"22","author":"Krishnan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.micpath.2026.108412_bib95","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01657-22","article-title":"A novel cryptic clostridial peptide that kills bacteria by a cell membrane permeabilization mechanism","volume":"10","author":"Szadkowska","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"4","key":"10.1016\/j.micpath.2026.108412_bib96","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/biomedicines9040429","article-title":"Targeting of the essential acpP, ftsZ, and rne genes in carbapenem-resistant Acinetobacter baumannii by antisense PNA precision antibacterials","volume":"9","author":"Nejad","year":"2021","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.micpath.2026.108412_bib97","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.3390\/cells9112401","article-title":"The microbiota and gut-related disorders: insights from animal models","volume":"9","author":"Kamareddine","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib99","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2387139","article-title":"Pseudocin 196, a novel lantibiotic produced by Bifidobacterium pseudocatenulatum elicits antimicrobial activity against clinically relevant pathogens","volume":"16","author":"Sanchez-Gallardo","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.micpath.2026.108412_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.929242","article-title":"Blue-mediated antimicrobial photodynamic therapy against clinical isolates of extensively drug resistant Gram-negative bacteria causing nosocomial infections in Thailand, an in vitro study","volume":"12","author":"Songsantiphap","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108412_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2023.1259435","article-title":"Biomaterials-mediated CRISPR\/Cas9 delivery: recent challenges and opportunities in gene therapy","volume":"11","author":"Dubey","year":"2023","journal-title":"Front. Chem."},{"issue":"7","key":"10.1016\/j.micpath.2026.108412_bib102","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/ph16070920","article-title":"CRISPR-based gene editing in Acinetobacter baumannii to combat antimicrobial resistance","volume":"16","author":"Junaid","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.micpath.2026.108412_bib103","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3390\/ph16091281","article-title":"An update on the therapeutic potential of antimicrobial peptides against Acinetobacter baumannii infections","volume":"16","author":"Rangel","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.micpath.2026.108412_bib104","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/antibiotics13010039","article-title":"GATR-3, a peptide that eradicates preformed biofilms of multidrug-resistant Acinetobacter baumannii","volume":"13","author":"van Hoek","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.micpath.2026.108412_bib105","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02511-23","article-title":"Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates","volume":"12","author":"Vijayakumar","year":"2024","journal-title":"Microbiol. Spectr."},{"issue":"2","key":"10.1016\/j.micpath.2026.108412_bib106","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04773-22","article-title":"Heterocyclic diaryliodonium-based inhibitors of carbapenem-resistant Acinetobacter baumannii","volume":"11","author":"Kumari","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"2","key":"10.1016\/j.micpath.2026.108412_bib107","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3947\/ic.2024.0055","article-title":"Optimizing treatment for carbapenem-resistant Acinetobacter baumannii complex infections: a review of Current evidence","volume":"56","author":"Choi","year":"2024","journal-title":"Infect Chemother."},{"issue":"7995","key":"10.1016\/j.micpath.2026.108412_bib108","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-023-06873-0","article-title":"A novel antibiotic class targeting the lipopolysaccharide transporter","volume":"625","author":"Zampaloni","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108412_bib109","series-title":"Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2022","year":"2022"},{"key":"10.1016\/j.micpath.2026.108412_bib110","article-title":"Global antibiotic research and development partnership","year":"2023","journal-title":"Annual report"},{"key":"10.1016\/j.micpath.2026.108412_bib111","series-title":"Supporting Countries to Tackle Antimicrobial Resistance (AMR)","year":"2023"},{"issue":"4","key":"10.1016\/j.micpath.2026.108412_bib113","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A deep learning approach to antibiotic discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.micpath.2026.108412_bib114","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/vaccines12040358","article-title":"Development and evaluation of an immunoinformatics-based multi-peptide vaccine against Acinetobacter baumannii infection","volume":"12","author":"Jeffreys","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.micpath.2026.108412_bib115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/vaccines13030236","article-title":"An immunoinformatics-based multi-peptide vaccine provides antibody-mediated protection against Acinetobacter baumannii infection","volume":"13","author":"Jeffereys","year":"2025","journal-title":"Vaccines (Basel)"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026001385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026001385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:19:02Z","timestamp":1776122342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026001385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":114,"alternative-id":["S0882401026001385"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108412","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global strategies to fight carbapenem-resistant Acinetobacter baumannii (CRAB) infections","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108412"}}